Paeoniflorin exerts antitumor effects by inactivating S phase kinase-associated protein 2 in glioma cells

Jia Ouyang1, Hui Xu1, Ming Li1

  • 1Department of Neurosurgery, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China.

Oncology Reports
|December 30, 2017
PubMed

Insights

Paeoniflorin (PF) inhibits glioma progression by downregulating S-phase kinase-associated protein 2 (Skp2). This natural compound shows promise as a therapeutic agent for glioma, targeting key oncogenic pathways.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Paeoniflorin (PF), derived from Paeoniae radix, exhibits antitumor properties against various cancers, including glioma.
  • The precise mechanism underlying PF's anti-glioma effects remains unclear.
  • S-phase kinase-associated protein 2 (Skp2) is recognized as an oncogene implicated in numerous cancer types.

Purpose of the Study:

  • To investigate if Skp2 mediates the anti-glioma activity of Paeoniflorin (PF).
  • To elucidate the molecular mechanisms by which PF exerts its effects on glioma cells.

Main Methods:

  • Assessing the impact of PF on glioma cell proliferation, migration, invasion, cell cycle progression (G2/M arrest), and apoptosis.
  • Analyzing Skp2 expression levels in PF-treated glioma cells.
  • Evaluating the effects of Skp2 overexpression and RNA interference on PF's anti-glioma actions.
  • Testing PF's efficacy in a U87 cell-derived xenograft mouse model.

Main Results:

  • Paeoniflorin (PF) significantly inhibited glioma cell proliferation, migration, and invasion.
  • PF treatment induced G2/M cell cycle arrest and promoted apoptosis in glioma cells.
  • PF downregulated Skp2 expression in glioma cells.
  • Overexpression of Skp2 abolished PF's anti-glioma effects, while Skp2 inhibition enhanced them.
  • PF treatment suppressed tumor growth in a xenograft mouse model.

Conclusions:

  • Paeoniflorin (PF) exerts its antitumor effects in glioma, at least partly, by inhibiting Skp2 expression.
  • PF demonstrates potential as a therapeutic agent for glioma treatment, targeting Skp2-mediated pathways.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
X-Inactivation01:58

X-Inactivation

The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
42.7K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
11.7K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.6K
Phase Transitions02:31

Phase Transitions

Whether solid, liquid, or gas, a substance's state depends on the order and arrangement of its particles (atoms, molecules, or ions). Particles in the solid pack closely together, generally in a pattern. The particles vibrate about their fixed positions but do not move or squeeze past their neighbors. In liquids, although the particles are closely spaced, they are randomly arranged. The position of the particles are not fixed—that is, they are free to move past their neighbors to...
23.3K